Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1186 of 5804
-
Laser light offers hope for chemo nerve pain in new trial
Symptom relief Recruiting nowChemotherapy-induced peripheral neuropathy (CIPN) (including taxanes, platinum, al pervenche from Madagascar alkaloids...), is a frequent secondary effect of treatments: 68% at 1-month post-chemotherapy, 60% at 3 months and 30% after 6 months. Symptoms associated with CIPN are us…
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New hope for elderly esophageal cancer patients: immunotherapy without chemo
Disease control Recruiting nowThe goal of this clinical trial is to assess the percentage of patients alive at 6 months in elderly patients, not eligible to an platinum-based chemotherapy, but who can received the Tislelizumab treatment alone as first-line treatment for an advanced esophageal squamous-cell ca…
Phase: PHASE2 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New study aims to help cancer survivors ditch opioids for good
Symptom relief Recruiting nowThis proposal is relevant to the 240,000 cancer survivors who continue to use opioids long after they have successfully completed treatment for cancer at the VHA, placing them at risk of opioid addiction and overdose, and other opioid-related problems. Yet, there are no programs …
Phase: PHASE4 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Personalized blood thinners could slash stroke risk
Disease control Recruiting nowStroke is an important cause of death, disability, and memory problems in adults. The build-up of plaque in arteries inside the brain is known as "intracranial atherosclerotic disease" or "ICAD" for short, and can reduce blood flow in the brain. Clopidogrel is a medicine used to …
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New CAR t cell therapy targets Hard-to-Treat lung cancer
Disease control Recruiting nowThis is a Phase I open-label clinical trial to assess the safety, feasibility, and preliminary efficacy of intrapleural administration of MOv19-BBz CAR T cells in patients with FRa+ cancers. This study will be initiated in patients with metastatic or recurrent non-small cell lung…
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo could help heart defect patients with severe lung pressure
Disease control Recruiting nowWhat is this study about? This study will test whether adding sotatercept to usual medicines for pulmonary arterial hypertension (PAH) can help adults who have PAH due to unrepaired congenital heart defects (atrial or ventricular septal defect, or patent ductus arteriosus), inclu…
Phase: PHASE4 • Sponsor: Kazuya Hosokawa • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
AI and Finger-Prick test could spot hidden heart failure in pacemaker patients
Diagnosis ENROLLING_BY_INVITATIONPacemakers are an effective treatment for slow heart rates which improve symptoms and save lives. However, for some people pacemakers can cause heart failure (HF) because of the unnatural way in which they stimulate heart beats. In several studies conducted in West Yorkshire we s…
Sponsor: University of Leeds • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
Fiber fuel: could a High-Fiber diet supercharge lung cancer treatment?
Symptom relief Recruiting nowIn the present study 'Fiber-Boost', we investigate how a high-fiber diet affects the immunotherapy of advanced lung cancer and what effects it has on the gut microbiome (i.e., the bacteria in the gut) as well as the immune system. Study participants will be assigned to either a t…
Phase: NA • Sponsor: Cantonal Hospital of St. Gallen • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
At-Home style HPV test at Walk-In clinics could boost cancer screening
Prevention ENROLLING_BY_INVITATIONThis clinical trial evaluates whether offering human papillomavirus (HPV) self-collection for cervical cancer screening at Mayo Clinic Express Care clinics improves uptake of cervical cancer screening and receipt of appropriate follow-up care. Cervical cancer is preventable throu…
Phase: NA • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Jun 27, 2026 13:04 UTC
-
Shocking stroke recovery: nerve zaps + robots show promise
Symptom relief Recruiting nowStroke is one of the leading causes of death and permanent disability worldwide. Loss of upper extremity (UE) function after stroke significantly reduces independence and quality of life. Moreover, weakness in the respiratory muscles negatively affects trunk control and respirato…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Weight-Loss drug tirzepatide takes on alcohol addiction in new trial
Disease control Recruiting nowThe objective of this Phase 2 randomized controlled trial is to evaluate the effects of weekly tirzepatide (vs. placebo) on alcohol consumption and cardiometabolic outcomes in adults with alcohol use disorder and overweight or obesity.
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can teaching kids kindness and mindfulness boost their grades and well-being?
Symptom relief CompletedThis randomized controlled trial aims to evaluate the efficacy of a Mindfulness and Compassion program to improve emotional and behavioral problems, academic performance and school climate of students in the last cycle of Primary Education. Participants will be randomly assigned…
Phase: NA • Sponsor: Universidad de Zaragoza • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New drug combo could simplify breast cancer treatment for younger women
Disease control Recruiting nowA prospective randomized trial designed to evaluate the mean decrease in Ki67 after 4 weeks of elacestrant monotherapy and in combination with leuprorelin in patients with early-stage HR+ BC. This preoperative study will enroll consecutive patients with early stage HR+ BC who are…
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
AI-Powered smartwatch could forecast Parkinson's worsening
Knowledge-focused Not yet recruitingThe study aims to provide initial PoC validation data of two AI models to predict disease progression and treatment side effects in PD patients using as input patients' demographic, clinical and genetic information, as well as digital biomarker measurements in daily living collec…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Could a gene therapy shot boost brain health? new study begins
Disease control Recruiting nowThe purpose of this study is to investigate the safety and efficacy of a gene therapy for Klotho, delivered via a nonviral plasmid in healthy adult volunteers. Additionally, this study seeks to understand the cognitive and health benefits of the Klotho gene therapy.
Phase: PHASE1 • Sponsor: Minicircle • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could sotatercept help PAH patients breathe easier?
Disease control Recruiting nowThe goal of this clinical trial is to determine whether sotatercept is effective in improving diffusing capacity in patients with pulmonary arterial hypertension. Participants will be asked to: * Take Sotatercept every 21 days (±3 days) * Each participant will be enrolled in th…
Phase: PHASE4 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Radioactive bullet targets Hard-to-Treat breast cancer
Disease control Recruiting nowThis is a FiH phase 1, open-label, two-stage, randomized trial to assess the safety, tolerability, and biodistribution of \[177Lu\]Lu-ABY-271 in subjects with HER2 positive metastatic breast cancer.
Phase: PHASE1 • Sponsor: Affibody • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New tablet program aims to ease suicidal thoughts in teens stuck in ER limbo
Symptom relief Recruiting nowWhen presenting to an ED with suicide, self-harm or other mental health crises, youth may also experience "boarding", which is defined by the Joint Commission as "the practice of holding patients in the ED or another temporary location after the decision to admit or transfer has …
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
AI could help family doctors catch hidden heart disease
Diagnosis Not yet recruitingThe DAISEA-ECG project aims to improve the diagnosis of heart diseases in primary care through the DeepECG platform, which combines ECG-AI and ECHONeXT algorithms. This study uses a stepped wedge design, where each Family Medicine Group acts as its own control. The FMGs will grad…
Phase: NA • Sponsor: Montreal Heart Institute • Aim: Diagnosis
Last updated Jun 26, 2026 19:10 UTC
-
New combo therapy aims to beat staph blood infections
Disease control Recruiting nowThe aim of the study is to assess whether targeting virulence factors by administering linezolid in addition to standard antibiotic treatment improves outcomes in patients with Staphylococcus aureus bacteraemia.
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC